Technology

Arcweb Technologies unveils open-source clinical research platform Arcwell

Published

3 months ago

October 21, 2024

Arcwell is a free, open-source platform designed to accelerate the development of clinical trials and wellness protocols by providing out-of-the-box tools. Already successfully implemented at two major hospitals, Arcwell helps healthcare organizations reduce development costs and time to market.

PHILADELPHIA, Oct. 21, 2024 /PRNewswire-PRWeb/ — Arcweb Technologies, a Philadelphia-based digital product company, today announced the release of Arcwell, a free, open-source platform for delivering wellness protocols to the public.

“Imagine a world where patients can access free, evidence-based wellness protocols from their phones in a completely secure, private environment,” says Arcweb CEO Chris Cera. “That’s the world we’re building with Arcwell. We’re reaching out to vision-aligned clinical leaders at healthcare providers and contract research organizations to co-create the future of low-cost care delivery.”

As launched today, healthcare organizations can use Arcwell to design, build, and deploy clinical trials and wellness protocols, taking advantage of the robust rules engine to facilitate autonomous clinical operations and decision support. Planned updates include SDKs for developers to leverage when integrating Arcwell in their applications and a FHIR-compliant electronic health record (EHR) system for cache, local record, and integration with health systems.

For healthcare organizations of any size, Arcwell improves cost and speed to market. It enables organizations to conduct Electronic Clinical Outcome Assessments (eCOA) and collect Patient Reported Outcomes (ePRO) within an Electronic Data Capture (EDC) system, confident that their study can easily graduate on the same infrastructure. And, since Arcwell is released under the Apache2 open-source software license, vendor lock-in and total cost of ownership are drastically reduced.

In addition to making the source code freely available on GitHub, Arcweb has successful Arcwell implementations with two healthcare institutions:

Researchers at the Perelman School of Medicine at the University of Pennsylvania used the Arcwell platform to power a clinical trial evaluating the effectiveness of a patient navigation tool for antepartum anemia. “When we designed this clinical study, we needed a clinical research platform that made being part of the study easy and appealing for participants and that allowed us to securely and privately collect, analyze and report on findings,” said the study’s lead author Natasha Kumar, MD, a former fellow in Maternal Fetal Medicine at Penn. “The platform also needed to be flexible enough to support the study without too much overhead. Tools like this are vital to researchers.””Our custom decision support tool, built on top of Arcwell, enables us to stay on the cutting edge of neonatal resuscitation,” says Tom Reynolds, Business Manager at another healthcare organization. “It handles our 4,000+ custom clinical rules with ease, which is crucial to ensure our clinicians have the right information at the right time.”

Arcweb is actively soliciting input from clinical champions to inform Arcwell’s development roadmap. “We want this effort to be as inclusive as possible,” says Cera. “We want to hear from any provider, clinical research organizer or pharma innovator with a promising new intervention they’re trying to test. We envision a future where Arcwell is leveraged across a broad range of use cases, including those we haven’t even thought of yet, from developing AI-driven applications and digital companions, to enabling digital diagnostics, identifying digital biomarkers, supporting remote patient monitoring (RPM), advancing telehealth solutions, and driving real-world evidence (RWE) initiatives. Our goal is to create a flexible platform that can power the next generation of healthcare innovations. We want real world use cases to inform the finished product, so it has the greatest impact possible.”

Arcwell is distributed under the open-source Apache 2.0 license, and is available to download on GitHub.

To find out how you can help shape Arcwell’s future, visit https://arcwell.health

To get in touch with the Arcweb Technologies Team, visit https://arcwebtech.com/contact/

Media Contact

Mia Kent, Arcweb Technologies, 1 8008467980, marketing@arcwebtech.com, Arcwebtech.com

View original content to download multimedia:https://www.prweb.com/releases/arcweb-technologies-unveils-open-source-clinical-research-platform-arcwell-302281989.html

SOURCE Arcweb Technologies

Technology

Singapore’s Sodion Energy Secures MWh Supply of US Developed Advanced Sodium-Ion Batteries from UNIGRID

Published

1 minute ago

January 12, 2025

SINGAPORE, Jan. 13, 2025 /PRNewswire/ — Sodion Energy, a leading provider of sodium-ion batteries for e-mobility and integrated energy storage solutions in Southeast Asia, has secured a landmark agreement for an initial 10 MWh supply of advanced sodium-ion batteries developed by UNIGRID Inc., a California-based innovator in sodium-ion battery technology.

This collaboration strengthens Sodion Energy’s ability to address the region’s rising demand for affordable, eco-friendly, and high-performance battery solutions across mobility and energy storage sectors.

“Our collaboration with UNIGRID is a game-changer,” said Dr. CC Hang, Chairman of Sodion Energy. “These next-generation sodium-ion batteries will allow us to tackle key markets, starting with lead-acid battery replacements in e-mobility and extending into large-scale renewable energy projects and grid stabilization initiatives.”

Sodium-ion batteries offer distinct advantages, including cost-efficiency, enhanced safety, and the use of abundant raw materials, making them a sustainable choice for energy storage. With fast-charging capabilities and intrinsic non-flammability, they are exceptionally suited to Southeast Asia’s tropical climate and rapidly growing energy needs.

With a strategic focus on advanced battery technologies, Sodion Energy is poised to play a key role in driving Southeast Asia’s transition to cleaner, safer, and more sustainable energy solutions.

Website: https://sodione.com

About Sodion Energy

Headquartered in Singapore, Sodion Energy is an applications engineering leader driving the commercialization of Sodium-ion batteries across Southeast Asia. SE’s sodium-ion pack solutions are tailored to meet the diverse needs of industries such as mobility and energy storage, contributing to a more sustainable future.

View original content:https://www.prnewswire.com/apac/news-releases/singapores-sodion-energy-secures-mwh-supply-of-us-developed-advanced-sodium-ion-batteries-from-unigrid-302347661.html

SOURCE UNIGRID and Sodion Energy Pte. Ltd

Technology

AirCheck Australia & New Zealand Renamed as RCS MEDIA MONITORS

Published

1 hour ago

January 12, 2025

SYDNEY, Jan. 13, 2025 /PRNewswire/ — AirCheck, a leading provider of broadcast monitoring services in Australia and New Zealand is pleased to announce its renaming as RCS MEDIA MONITORS, effective immediately.

AirCheck monitors songs and commercials providing almost real time reporting tools for radio and television broadcasters, music media, record companies, advertising agencies and industry analysts.

This change reflects the company’s growth, expanded service offerings, and a strengthened focus on providing comprehensive media intelligence.

The new name, RCS MEDIA MONITORS, builds on the expertise of its parent company, RCS, to offer enhanced monitoring solutions. By integrating RCS’s global technology and resources, the company will provide clients with a broader range of tools for tracking and analysing media campaigns across a variety of platforms and markets.

“We’re excited to take this step forward,” said Philippe Generali, President and CEO of RCS Global. “The rebranding to RCS MEDIA MONITORS allows us to expand our reach and improve our services, giving clients access to deeper insights and a wider array of media monitoring tools. With RCS’s support, we can offer more robust data and solutions that cover not just broadcast, but also digital and emerging media channels.”

The name change signals the company’s commitment to evolving with the changing media landscape. With RCS MEDIA MONITORS, clients can expect the same reliable monitoring services they’ve trusted for over 20 years in Australia and 15 years in NZ.

www.rcsmediamonitors.com.au

About RCS MEDIA MONITORS

RCS MEDIA MONITORS (formerly AirCheck) is a leading provider of broadcast monitoring and media intelligence solutions in Australia, New Zealand and India. The company helps clients across industries optimise media strategies, measure performance, and gain insights from a wide range of traditional and digital media. RCS MEDIA MONITORS is part of RCS, a global leader in broadcast automation and media technology.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/aircheck-australia–new-zealand-renamed-as-rcs-media-monitors-302347810.html

SOURCE RCS MEDIA MONITORS

Technology

iM Global Partner mourns the passing of Philippe Uzan

Published

1 hour ago

January 12, 2025

PARIS, Jan. 13, 2025 /PRNewswire/ — It is with deep sadness that iM Global Partner (iMGP) announces the passing, one month ago, of our dear friend and colleague, Philippe Uzan.

Philippe’s exceptional career in asset management spanned more than 30 years and is marked by remarkable achievements in the organizations for which he worked and deep contributions to the industry as a whole. His passing is a tremendous loss to all who knew and worked with him.

Philippe joined iM Global Partner in February 2020 as Deputy CEO and CIO Global Asset Management, responsible for overseeing our financial strategies and products and designing value-added investment solutions for our clients across Europe and the United States.

His expertise spanned all asset classes, and he had a deep understanding of markets and their impact on investors and their investment needs. He was an eloquent man who contributed a number of papers and articles to the media, always with the intention of educating and making financial concepts more relatable. He has left an indelible mark on our organization and on the broader industry.

Prior to joining iM Global Partner, Philippe was latterly Chief Investment Officer at Edmond De Rothschild Asset Management, where he worked for 11 years and where he led the portfolio management teams, optimizing the synergies between analysis and portfolio management. He previously spent three years as Research and Global Asset Allocation Director, where he developed the portfolio management and research teams and modernized investment processes and the product range.

Philippe began his career as an Equity Derivatives Trader at Société Générale and held roles at AGF Asset Management (now part of Allianz Global Investors) and Natixis AM.

Throughout his career, Philippe’s outstanding intelligence, humility, and collaborative spirit earned him the respect and admiration of his peers.

Philippe Couvrecelle, Founder and CEO of iM Global Partner, expressed his heartfelt condolences: “It was with infinite sadness and pain that I learned of Philippe’s passing from a devastating illness. I had known Philippe closely for almost 20 years, as we worked together for Natixis, Edmond de Rothschild and iMGP. I pay immense tribute to his humanity, his sense of humor, his brilliant intelligence and his presence, which I will deeply miss. We had shared so much and still had so much to do together. In his memory, we will continue our path forward with strength, success and intensity, always preserving our values and our company culture to which he was so attached.

We will all miss Philippe enormously at iM Global Partner. He will be remembered not only for his professional achievements but also for his warmth, generosity, kindness and his unwavering dedication to his colleagues and community. Our thoughts are with his wife and three children, his family, friends and loved ones during this difficult time.”

CONTACT: media@imgp.com

SOURCE iM Global Partner